New diagnosis strategy for adult obstructive apnea syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024044

Enrollment

Unknown

Registered

2019-06-23

Start date

2019-06-30

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adult obstructive apnea syndrome

Interventions

Gold Standard:polysomnography,PSG

Index test:drug&#32

induced&#32

polysomnography,DIPSG

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Consecutive patients who visited snoring clinic complaining a history of snoring or apnea; 2. Aged 18-65 years, no limit on gender; 2. Confirmed healthy volunteers without OSA by PSG.

Exclusion criteria

Exclusion criteria: 1. Patients have undergone upper airway surgery, 2. Suffering from severe systemic diseases, such as myocardial ischemia, heart failure, chronic obstructive pulmonary disease; 3. Allergic or contraindication to dexmedetomidine.

Design outcomes

Primary

Measure	Time frame
apnea hypopnea index;SEN, SPE, ACC, PLR, NLR, AUC of ROC;	—

Secondary

Measure	Time frame
End-tidal carbon dioxide;Minimum oxygen saturation;	—

Countries

China

Contacts

Public ContactWeiping Wen

The First Affiliated Hospital, Sun Yat-Sen University

wenwp@mail.sysu.edu.cn+86 13802966937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026